Independent research tool — not a government agency. Official notices govern.Refreshed
ForecastedOpportunity CDC-RFA-PS-27-0009

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP)

Centers for Disease Control - NCHHSTP · Department of Health and Human Services

At a glance

Integrated Viral Hepatitis Surveillance, Testing, Treatment, and Prevention Programs for Health Departments (IVH-STTP) is a forecasted federal cooperative agreement opportunity from the Centers for Disease Control - NCHHSTP (Department of Health and Human Services). The agency's forecast estimates an application due date of February 16, 2027; forecast dates can change. Total estimated funding is $450M across about 60 awards. Applicant types listed as eligible include state governments, county governments, city or township governments, special district governments and others (see notice). Cost sharing is not required. It is funded under Assistance Listing 93.270 (Viral Hepatitis Prevention and Control).

Summary assembled from the official notice's fields. The official notice governs.

Key facts

  1. Jun 9, 2026Forecast posted
  2. Dec 1, 2026 (est.)Full notice expectednext date
  3. Feb 16, 2027 (est.)Application deadline
  4. Apr 1, 2027 (est.)Est. award date
Posted
Jun 9, 2026
Est. close date
Feb 16, 2027
Est. award date
Apr 1, 2027
Award floor
Not specified
Award ceiling
Not specified
Est. total funding
$450,000,000
Expected awards
60
Cost sharing
Not required
Funding instrument
Cooperative Agreement
Opportunity category
Discretionary
Fiscal year
FY2027

Who can apply

  • State governments
  • County governments
  • City or township governments
  • Special district governments
  • Others (see notice)

Additional information on eligibility (from the notice)

Eligible applicants include: The 51 state health departments or their bona fide agents, including the District of Columbia. Local health agencies or their bona fide agents. If the city does not have a public health department, then the county covering the jurisdiction may apply (i.e., Los Angeles, CA covered by Los Angeles County and Phoenix, AZ covered by Maricopa County). All U.S. territories Bona fide agents must submit documentation that demonstrates their arrangement with the eligible applicant.

A quick check against the listed applicant types — other requirements in the notice still apply.

Based on the published notice. Review the official notice for complete eligibility requirements.

What it funds

Official synopsis as published by the agency, formatted for readability.

This NOFO supports integrated viral hepatitis surveillance and prevention programs in states, territories, and large cities in the United States. Key strategies include viral hepatitis outbreak response and surveillance for hepatitis A, acute and chronic hepatitis B, and acute, chronic, and perinatal hepatitis C. Surveillance activities include developing and utilizing disease registries, conducting data matching, generating data summaries, utilizing data to monitor program progress and inform program activities and to enhance case investigations for data-to-care opportunities, and strengthening health department infrastructure to expand surveillance capacity. Prevention activities include supporting viral hepatitis elimination planning, partnerships, and coordination in high-impact and healthcare settings, increasing hepatitis B and hepatitis C testing, treatment, and service integration in high-impact settings, and developing perinatal hepatitis C programs. Expected outcomes include improved surveillance and reporting of viral hepatitis, improved strategic planning and partner collaboration in viral hepatitis elimination, and expanded access to viral hepatitis prevention, diagnosis, and treatment in high-impact settings.

This multi-component NOFO includes two required components and two optional components:

  • Component 1: Outbreak Response and Surveillance (Required)
  • Component 2: Planning, Partnerships, and Promotion (Required)
  • Component 3: Testing, Treatment, and Prevention (Optional)
  • Component 4: Perinatal Hepatitis C Program (Optional)

This NOFO is alignment with CDC priorities. 

How to apply

0 of 8 done · progress saved in this browser

Assistance Listing

What is an ALN?

Reported obligations under ALN 93.270

Historical data · not a prediction
FY24$25.4M
FY25$22.1M
FY26$22M est.
Source: SAM.gov Assistance Listing 93.270. Program-wide totals, not awards from this specific opportunity.

Agency contact (as published)

Clarisse Tsang
mix4@cdc.gov
404-718-5360

Quick answers

Is this opportunity open for applications yet?

Not yet. It is a forecast — an agency's advance notice of an expected opportunity. The agency estimates posting the full notice around December 1, 2026. Forecast details and dates can change.

Who is eligible to apply for this opportunity?

The official notice lists these applicant types as eligible: State governments, County governments, City or township governments, Special district governments and Others (see notice). Additional restrictions may apply; review the full notice.

How much funding is available through this opportunity?

Per the notice, total estimated program funding is $450,000,000 and the agency expects to make about 60 awards.

How do I apply for this opportunity?

Applications are submitted through the official source, not through GrantsJunction. Open the official notice on Grants.gov (opportunity CDC-RFA-PS-27-0009), and review the full announcement and application package. Organizations applying through Grants.gov generally need an active SAM.gov registration and a Grants.gov account, which can take several weeks to set up.

Matched on shared Assistance Listings, agency, categories and eligible applicant types.

ForecastedALN 93.978
Award range
Amount not specified
Est. close
May 31, 2027 (est.)
Who can apply
State governments, County governments, City or township governments and 10 more
Source: Grants.govVerified today